Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT06003101
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Acetabular Labrum Tear
- Bone Marrow Aspirate Concentrate
- Chondral Defect
- Femoro Acetabular Impingement
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Bone marrow aspirate concentrate (BMAC) — BIOLOGICALBone marrow aspiration from the body of the ilium will be performed through one of the arthroscopic portals.
- Control — PROCEDUREStandard of care hip arthroscopy without bone marrow aspiration will be performed in these patients.
Study Details
The goal of this clinical trial is to assess the effect of PRP/PPP/BMAC application on functional outcomes after hip arthroscopy to address acetabular labral pathologies. The main questions it aims to answer are: 1. Does PRP/PPP/BMAC application improve functional outcomes after hip arthroscopy to address acetabular labral pathologies? 2. Does PRP/PPP/BMAC application reduce the arthritic burden as measured by functional outcomes following hip arthroscopy to address labral pathologies with concomitant PRP/PPP/BMAC application?
Key Dates
- Start date
- Aug 30, 2023
- Status verified
- Nov 2024
- Primary completion
- Aug 30, 2027
- Completion
- Aug 30, 2045
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Bone marrow aspirate concentrate (BMAC)Patients randomly allocated to receive BMAC will undergo hip arthroscopy and will receive PRP/PPP/BMAC application through the PI's standardized method of harvest, processing, and application.
- Placebo Comparator: ControlPatients allocated to the control cohort will receive standard of care hip arthroscopy without PRP/PPP/BMAC application.
Primary Outcome Measure
Pain Level [ Time Frame: Baseline (pre-operative), 3 months, 6 months, 12 months, and 24 months ]
Central Contacts
- Scott D. Martin, MD617-732-5329
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Scott D. Martin, MD |
Find similar trials in Boston, MA
By research site
Related Studies
- Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral TearRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Biomechanical Assessment of Femoroacetabular ImpingementEnrolling By Invitation · University of Utah · Salt Lake City, Utah
- A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the KneePHASE3 · Recruiting · Vericel Corporation · Palo Alto, California
- Concentrated Bone Marrow Aspirate in Revision ACL ReconstructionPHASE4 · Recruiting · Hospital for Special Surgery, New York · Atlanta, Georgia